Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-21,500
Closed -$177K – 556
2023
Q4
$177K Sell
21,500
-52,685
-71% -$434K 0.01% 400
2023
Q3
$618K Sell
74,185
-180,000
-71% -$1.5M 0.01% 380
2023
Q2
$2.13M Buy
254,185
+12,523
+5% +$107K 0.04% 283
2023
Q1
$1.97M Buy
241,662
+11,508
+5% +$91.7K 0.05% 314
2022
Q4
$1.84M Buy
230,154
+46,340
+25% +$315K 0.03% 482
2022
Q3
$1.12M Buy
+183,814
New +$1.19M 0.01% 732

Other funds holding HLN

UBS O'Connor's HLN Position: Q1 2024 in Review

UBS O'Connor sold out of Haleon (HLN) in Q1 2024, closing a stake of 21,500 shares — an estimated $177K sold.

UBS O'Connor first reported a position in HLN in Q3 2022 and held it in 6 quarters. The position peaked at $2.13M in Q2 2023. 601 funds tracked by Wall St. Rank hold HLN as of Q1 2024.

  • UBS O'Connor reported no remaining Haleon position as of Q1 2024 after selling out during the quarter.
  • UBS O'Connor sold 21,500 Haleon shares in Q1 2024, an estimated $177K.
  • UBS O'Connor first reported a position in Haleon in Q3 2022 and held it in 6 quarters.
  • UBS O'Connor's Haleon position peaked at $2.13M in Q2 2023.
  • 601 funds tracked by Wall St. Rank held Haleon as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.